Recon: US to buy $1B more of Merck's COVID-19 pill; AstraZeneca to create new division for vaccines and antibodies
ReconMichael Mezher
Biologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy